Periprocedural antithrombotics dangerous for endovascular stroke treatment

Published On 2022-03-10 11:45 GMT   |   Update On 2022-03-10 11:45 GMT

Stroke treatment is very difficult. Antithrombotics are dangerous during stroke thrombectomy, according to a recent study published in the Lancet. Therefore giving Antithrombotics like IV aspirin and/or unfractionated heparin during endovascular stroke treatment does not seem to be a good idea reveals the MR CLEAN-MED trial.Aspirin and unfractionated heparin are often used during...

Login or Register to read the full article

Stroke treatment is very difficult. Antithrombotics are dangerous during stroke thrombectomy, according to a recent study published in the Lancet. Therefore giving Antithrombotics like IV aspirin and/or unfractionated heparin during endovascular stroke treatment does not seem to be a good idea reveals the MR CLEAN-MED trial.

Aspirin and unfractionated heparin are often used during endovascular stroke treatment to improve reperfusion and outcomes. However, the effects and risks of antithrombotics for this indication are unknown. They, therefore, aimed to assess the safety and efficacy of intravenous aspirin, unfractionated heparin, both, or neither started during endovascular treatment in patients with ischaemic stroke.

For more information check out the full story on the link below: 

Antithrombotics Administration During Endovascular Stroke Treatment Not Entirely Safe: Lancet

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News